The practical value of Bacitracin Test is not the plate or broth alone; it is the reproducibility of the susceptibility endpoint produced from it. The discussion below connects its documented role with preparation variables, controls, interpretation, and the limits of inference. Catalogue 9502 is discussed as a laboratory measurement component; implementation should follow the laboratory SOP and validated reference method.
Analytical scope and method role
Test used for differentiating group A streptococci from other beta-haemolytic streptococci belonging to different Groups. This test is intended as an aid in the diagnosis, requiring further tests to complete the diagnostic results.
Method principle
A paper disc impregnated with bacitracin is applied directly to an inoculated agar plate before incubation. Streptococcus pyogenes or group A Streptococcus (GAS), which are sensitive to bacitracin, produce a zone of inhibition around the disc, whilst other beta-haemolytic streptococci either grow right up to the edge of the disc or show a very small zone of inhibition.
Preparation and execution: controlled method points
Procedure: 1. Allow product to reach room temperature before use for minimizing condensation on the disc. 2. Using a sterile loop or swab inoculate evenly the surface of a blood agar plate with a pure culture of the test organism exhibiting the appropriate haemolysis from the primary isolation plate. 3. Using sterile forceps, apply one disc of Bacitracin Test to the surface of the inoculated agar. 4. Invert and incubate plates at 35 2°C for 18-24 hours in ambient air (or in atmosphere with 5-10% CO2). 5. Examine for an inhibition zone around the disc.
Translate the method into controlled worksheet fields: catalogue and lot, preparation mass or volume, water quality, pH where applicable, heating or sterilization, supplements, dispense volume, preparation date, expiry assignment, incubation atmosphere and temperature, reading window, equipment, and analyst. Record departures as deviations instead of silently normalizing them.
Quality control: what the control result protects
organisms. REAGENTS • Each disc is impregnated with 0.04 IU of Bacitracin SPECIMEN Collect specimens in sterile containers or with sterile swabs and transport to the laboratory. Process each specimen using procedures appropriate for that sample. This product is recommended for use only with pure cultures. Refer to specific guidelines for more detailed information.
Challenge both sides of performance. Include a target reaction demonstrating recovery and, when relevant, a non-target or alternate reaction challenging inhibition or differentiation. Record expected and observed responses, acceptance criteria, strain and passage, lot, incubation, and disposition. A failed control blocks result interpretation until the cause is resolved.
Interpretation and confirmation pathway
The test organism is considered sensitive (S) to 0.04 IU bacitracin and presumptively S. pyogenes if a zone of inhibition is formed around the disc. No zone of inhibition (growth up to and around disc) indicates that the test organism is resistant (R) to 0.04 IU bacitracin and is not S. pyogenes.
Record the raw observation before the conclusion: morphology or colour, growth pattern, endpoint, reaction intensity, reading time, and control response. Presumptive reactions remain presumptive. Route atypical, weak, mixed, or delayed reactions through the confirmation step in the current method.
Storage, stability, and pre-use inspection
Store Bacitracin Test at -20°C/+8°C in the original packaging. Keep away from sources of heat and avoid excessive changes in temperature. Once opened from the desiccant-containing packaging, discs should be stored at 2-8°C and used within 7 days. Do not use the product beyond the expiry date indicated on the label. Eliminate without using if there are signs of deterioration. © Liofilchem - Bacitracin Test - Rev.1 / 13.05.2024 Page 2 of 7
Receipt and storage records should reconstruct temperature exposure, lot rotation, expiry, container integrity, and time outside controlled storage. Inspect colour, clarity, fill volume, gel integrity, contamination, dehydration, and precipitate before use.
Limitations and boundaries of use
Bacitracin susceptibility is a presumptive test only. Further biochemical and/or serological tests are needed to confirm identification. Different concentrations of bacitracin produce different zone sizes. Bacitracin test discs containing low level of bacitracin (0.04 UI) are differential tests only. Discs with a higher concentration of bacitracin (10 units) are used for antimicrobial susceptibility testing (AST).
Applicability depends on matrix, target organism, interfering flora, inoculum, validated method, and regulatory setting. Do not transfer conditions or acceptance criteria from a different matrix without verification.
Troubleshooting from evidence, not guesswork
- Poor recovery: check preparation, pH, overheating, supplement addition, inoculum, atmosphere, storage, and control performance.
- Loss of selectivity: review formulation, sterilization, expiry, inoculum burden, enrichment sequence, and incubation time.
- Weak or atypical reaction: confirm reading time and atmosphere, compare controls, document mixed growth, and follow confirmation requirements.
- Run-to-run drift: trend lot, analyst, equipment, water, preparation batch, controls, and environmental conditions.
External method context
The product should be understood as one measurement component in an antimicrobial susceptibility method. The analytical chain includes isolate purity, standardized inoculum, medium composition, antimicrobial concentration, incubation atmosphere and time, endpoint reading, and the interpretive table selected by the laboratory. A shift in any upstream variable can move an MIC or zone without a change in organism biology, which is why QC distributions and trend review are more informative than a single pass/fail control.
External laboratory-quality guidance also supports a lifecycle view: verify the method when introduced, bridge new lots against an accepted lot, trend control results, investigate nonconformities, and retain enough raw observations to reconstruct the decision. This is the practical difference between reproducing a preparation instruction and demonstrating that the resulting measurement is fit for its intended use.
EUCAST disk diffusion and quality control
EUCAST requires standardized methodology, current breakpoint tables, and routine quality control; the laboratory remains responsible for the final susceptibility report. For broth dilution, inoculum density, cation content, pH, incubation atmosphere, endpoint definition, and two-fold dilution design influence MIC reproducibility. Breakpoints are interpretive rules applied after a technically valid MIC or zone measurement; they are not properties of the product alone. Review the authoritative source.
FDA Bacteriological Analytical Manual
FDA BAM methods organize food microbiology around validated sampling, preparation, enrichment, isolation, and confirmation steps, with method applicability tied to the matrix and target organism. Sampling uncertainty, homogenization efficiency, inhibitory ingredients, dilution design, and countable range can dominate the result before the culture medium is ever inoculated; those variables belong in method verification and uncertainty review. Review the authoritative source.
WHO Laboratory Quality Management System handbook
WHO laboratory quality guidance treats document control, equipment, purchasing and inventory, process control, records, occurrence management, and continual improvement as connected parts of reliable testing. Review the authoritative source.
Technical references
- Manufacturer product documentation for catalogue 9502.
- EUCAST disk diffusion and quality control (access checked 2026-07-20).
- FDA Bacteriological Analytical Manual (access checked 2026-07-20).
- WHO Laboratory Quality Management System handbook (access checked 2026-07-20).
Bench-use checklist
- Verify product identity, catalogue number, lot, expiry, and storage history.
- Document preparation and incubation exactly as controlled in the SOP.
- Define controls and acceptance criteria before testing.
- Record raw observations, control response, reading time, and confirmation decision.
- Escalate failed controls, atypical reactions, and departures through the quality system.